J
Jack H. Freed
Researcher at Cornell University
Publications - 468
Citations - 24789
Jack H. Freed is an academic researcher from Cornell University. The author has contributed to research in topics: Electron paramagnetic resonance & Relaxation (NMR). The author has an hindex of 82, co-authored 459 publications receiving 23392 citations. Previous affiliations of Jack H. Freed include Dartmouth College & University of Freiburg.
Papers
More filters
Journal ArticleDOI
Local ordering and dynamics in anisotropic media by magnetic resonance: from liquid crystals to proteins.
Eva Meirovitch,Jack H. Freed +1 more
TL;DR: This property, the nature, magnitude and symmetry of the spatial restraints exerted at the site of the moving probe, is the main theme of the present review article and is outlined from both the theoretical and the experimental points of view, highlighting the new physical insights gained.
Journal ArticleDOI
Electron Spin-Echo Studies of Relaxation Times in Lithium-Methylamine Solutions
Journal ArticleDOI
Structural Dynamics by NMR in the Solid-State: The Unified MOMD Perspective Applied to Organic Frameworks with Interlocked Molecules
TL;DR: The microscopic-order-macroscopic-disorder (MOMD) approach for NMR lineshape analysis has been applied to the University of Windsor Dynamic Materials of type 1, 2, α-3, β-3 and 5, which are metal-organic frameworks comprising mobile mechanically-interlocked molecules (MIMs).
Proceedings ArticleDOI
ESR spectrometer at 250 GHz
Keith A. Earle,Jack H. Freed +1 more
TL;DR: In this article, the design principles of an electron spin resonance spectrometer operating at 250GHz were described, which uses quasi-optics to propagate the far-infrared radiation instead of conventional waveguide techniques.
Journal ArticleDOI
High-yield production in E. coli and characterization of full-length functional p13II protein from human T-cell leukemia virus type 1.
TL;DR: This study lays the foundation for expansion of in vitro functional and structural investigations on p13II and would aid in the development of structure-based protein inhibitors and markers.